Neuronetics, Inc.
NASDAQ: STIM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Daniel L. Reuvers
- Employees
- 716
- Headquarters
- Malvern, United States
- IPO year
- 2018
- Market cap
- $87.7M
- Website
- https://www.neurostar.com
Loading STIM…
Loading profile data…Frequently asked questions about STIM
What does Neuronetics, Inc. (STIM) do?
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, n...
Where does STIM trade?
Neuronetics, Inc. (STIM) trades on the NASDAQ Global Market.
What sector is STIM in?
Neuronetics, Inc. (STIM) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Neuronetics, Inc.?
Daniel L. Reuvers is the chief executive officer of Neuronetics, Inc. (STIM).
Where is Neuronetics, Inc. headquartered?
Neuronetics, Inc. is headquartered in United States.
Does STIM pay a dividend?
Neuronetics, Inc. (STIM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did STIM go public?
Neuronetics, Inc. (STIM) completed its initial public offering in 2018.